glp-1 parkinson's disease lancet Exenatide once a week versus

Evidence supporting combined therapy is emerging but remains limited as a recent meta-analysis of randomized controlled trials reported lower risk of HF hospitalization with concomitant SGLT2 inhibitor and GLP-1 receptor agonist therapy compared with monotherapy or standard care [24]

This provision adds flexibility for FY26, as agencies were unable to release new awards for over seven months

The appetite-suppressing effects of GLP-1 drugs like Ozempic and Wegovy are significantly reshaping consumer demand in the bakery and snack categories, Sheleena Jain, senior commodity specialist for WNS Procurement which is powered by research and analytics platform The Smart Cube told Bakery&Snacks

With regular use, it helps maintain a healthy skin barrier, improves skin texture, and gives the skin a radiant appearance